U.S. Federal Reserve Chair Jerome Powell has indicated that interest rates may rise faster than expected, which could have a significant impact on hospice M&A trends. Rate hikes are the Fed’s primary weapon against inflation, which climbed at a record pace last year. The U.S. Department of Commerce in January clocked the run of inflation […]
Interest Rates Likely to Rise, Impact PE Hospice Buyers Read More »
The Federal Trade Commission will give the public an additional 30 days to comment on a sweeping proposal to ban employers from imposing noncompete contracts on their workers. The agency said interested parties have requested an extension, though acknowledged others oppose the delay. The public now has until April 19 to comment on the proposed
FTC Pushes Back Deadline for Public to Weigh In on Noncompete Ban Read More »
Officials with a trade union representing hundreds of healthcare workers who would be affected by the proposed Sanford Health-Fairview merger are speaking out against the merger, and its members are urging for South Dakota lawmakers and the attorney general to get involved. Minnesota’s Attorney General opened an investigation into the proposed merger after it was
Hospice licensing should remain under the authority of state governments rather than federal agencies, though lawmakers “haven’t ruled anything out” when it comes to program integrity, according Rep. Beth Van Duyne (R-Texas). The congresswoman and fellow legislator Rep. Earl Blumenauer (D-Ore.) last month requested a briefing from the U.S. Centers for Medicare & Medicaid Services
Congresswoman Van Duyne: Hospice Licensing Should Remain with the States Read More »
The new telehealth restrictions proposed by the Drug Enforcement Administration (DEA) last week struck a sour chord with several industry stakeholders. Many industry insiders condemned the move as out of touch and even dangerous, jeopardizing telehealth models’ effectiveness in behavioral health. Still, the proposal is not set in stone, and parts of it could change
A United States bankruptcy court approved the $50 million sale of Borrego Health to DAP Health on Wednesday, the latest step for the troubled federally qualified health center to transfer operations of clinics to a like-minded center. The sale, which still faces some regulatory approvals, would dramatically expand Palm Springs-based DAP Health’s reach across Southern
Bankruptcy Court OKs Sale of Borrego Health to DAP Health; Regulatory Approval Pending Read More »
Amazon’s $3.9 billion acquisition of primary care company One Medical was finalized last week without a regulatory challenge. Consumer protection groups say the deal shouldn’t have been allowed to close, citing a number of concerns — some of which are shared by the Federal Trade Commission. The agency, which reportedly had prepared a lawsuit to
Why Regulators Didn’t Challenge Amazon-One Medical Deal, despite Data Concerns Read More »
Physician-owned hospitals might make a comeback thanks to congressional action supported by data crunched by lawyers and experts with the Department of Justice (DOJ), the Federal Trade Commission (FTC) and the American Medical Association (AMA). Last week, the Patient Access to Higher Quality Health Care Act (PDF) was reintroduced in Congress by Sen. James Lankford
Experts Push to Remove Barriers for Physician-Owned Hospitals Read More »
Hospitals could be playing defense this year as bipartisan scrutiny builds in Congress over the way facilities charge more for outpatient services that can be done in less-expensive settings, like a private doctor’s office. So-called site-neutral payment reforms could save Medicare upward of $100 billion over a decade, according to various projections, and those with
Hospital Outpatient Billing Draws Bipartisan Heat Read More »
The federal government is moving to require doctors to evaluate patients in person before writing prescriptions for some controlled medications, such as Adderall and OxyContin. The Drug Enforcement Administration announced Friday that it is seeking to revert rule changes under the COVID-19 public health emergency that allowed doctors to prescribe powerful drugs via telehealth appointments.
Biden Admin Seeks to Limit Telehealth Prescriptions for Some Drugs Read More »
